Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01026220 · OUTCOME

Event Free Survival

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Probability of survival
Interval / dispersion
95% Confidence Interval
Time frame
At 3 years from enrollment

What was measured

Survival from enrollment to first event: relapse/progression, second malignancy, or death.

Analysis population: 164 Group 1 All Patients received induction therapy.

Groups in this outcome

Group 1

All Patients

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Group 1164

Reported measurements

Source class 1
Values in Probability of survival · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Group 10.81Not reported0.740.86Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.74
        upper Limit
        0.86
        value
        0.81
denoms
  1. counts
    1. group Id
      OG000
      value
      164
    units
    Participants
description
Survival from enrollment to first event: relapse/progression, second malignancy, or death.
dispersion Type
95% Confidence Interval
groups
  1. description
    All Patients
    id
    OG000
    title
    Group 1
param Type
NUMBER
population Description
164 Group 1 All Patients received induction therapy.
reporting Status
POSTED
time Frame
At 3 years from enrollment
title
Event Free Survival
type
SECONDARY
unit Of Measure
Probability of survival

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice